MedPath

The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients

Withdrawn
Conditions
Ureteropelvic Junction Obstruction
Registration Number
NCT01711996
Lead Sponsor
Yonsei University
Brief Summary

Urinary Neutrophil gelatinase associated lipocalin (NGAL) has been recently reported to be related with the degree of hydronephrosis in pediatric ureteropelvic junction obstruction (UPJO) patients. We are trying to analyze whether it is related with the grade of renal injury in UPJO patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

<Group 1>

  1. 0-3 year old patients with SFU grade 2 or more hydronephrosis without ureteral dilatation

  2. needs pyeloplasty due to differential renal function (DRF)<40%, decreased DRF by more than 5%, development of urinary tract infection, development of urinary stone, and development of pain related with UPJO <Group 2>

  3. 0-3 year old patients with SFU grade 3 or 4 hydronephrosis without ureteral dilatation 2. doesn't meet the above criteria for the indication of pyeloplasty <Group 3>

  4. 0-3 year old children without any abnormality of urinary tract

Exclusion Criteria

<Group 1>

  1. patients with contralateral disease affecting DRF

  2. history of previous urinary tract surgery

  3. follow up loss before diuretic renogram performed at 6-12 months from operation <Group 2, 3>

  4. patients with contralateral disease affecting DRF 2. history of previous urinary tract surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The level of urinary NGAL and the degree of renal injury6 month after operation

Analysis of correlation between the level of urinary NGAL and the degree of renal injury

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath